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Abstract
We studied the potential use of [18F]ﬂuorodeoxyglucose (18F-FDG) whole body positron emission tomography (PET)–computed tomog-
raphy for the diagnosis of device infection and extension of infection. Twenty-one patients with suspected device infection were pro-
spectively included and compared with 14 controls free of infection. 18F-FDG uptake on the box and on the leads was visually and
quantitatively interpreted (using the maximal standard uptake value). The ﬁnal diagnosis was obtained either from bacteriological data
after device culture (n = 11) or by a 6-month follow-up according to modiﬁed Duke’s criteria (n = 10). Ten patients ﬁnally showed
infection on bacteriological study (n = 8) or during follow-up (n = 2). Sensitivity, speciﬁcity, positive predictive value and negative predic-
tive value were, respectively, 80%, 100%, 100% and 84.6% on patient-based analysis (presence or absence of infection). They were
100%, 100%, 100% and 100% for boxes, but only 60%, 100%, 100% and 73% for leads. Quantitative analysis could be useful for boxes
but not for leads, for which the presence of a mild hot spot was the best criterion of infection. The four false negatives on leads
received antibiotics for longer than the six true positives (20 ± 7.2 vs. 3.2 ± 2.3 days, p <0.01). Although the study was not designed
for this purpose, management could have been modiﬁed by PET results in six of 21 patients. 18F-FDG PET imaging may be useful for
the diagnosis of device infection, and could impact on clinical management. Interpretation of negative cases should be performed with
caution if patients have received antibiotics.
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Introduction
After pacemaker (PM) or implantable cardioverter-deﬁbrilla-
tor (ICD) implantation, device infection of box and/or leads,
although rare (0.5–5%, according to the most recent series,
giving an average of 2%) [1,2], is a feared and serious compli-
cation, leading to combined double antibiotherapy with com-
plete extraction of the material before discussion of
secondary re-implantation.
A positive diagnosis of box infection (or, more precisely,
infection of the pocket in which the box is implanted) may
be clinically suspected in cases of external suppuration, but
usually requires bacteriological samples to demonstrate septi-
caemia, associated with transthoracic echocardiography
(TTE) and transoesophageal echocardiography (TEE) to con-
ﬁrm images suggestive of vegetation on leads.
However, even when vegetation is demonstrated, differen-
tial diagnosis between infection and thrombus may be difﬁ-
cult [3]. Furthermore, infection staging and identiﬁcation of
other septic locations may be very important in order to
monitor treatment efﬁcacy before any re-implantation.
Inﬂammatory cells have a high afﬁnity for [18F]ﬂuoro-
deoxyglucose (18F-FDG), which explains the use of 18F-FDG
positron emission tomography (PET) imaging in pathological
processes that involve lymphocytes, plasmocytes and or/
macrophage inﬁltration [4–9]. Although neutrophils are the
hallmark of prosthetic infection, 18F-FDG uptake of mononu-
clear cells has been used for the diagnosis of infection such
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE INFECTIOUS DISEASES
as prosthetic infection [4–6], tuberculosis [7] or vascular
prothesis [9]. Therefore, whole body 18F-FDG PET imaging
could be useful for the diagnosis of device infection. Never-
theless, 18F-FDG PET imaging is not free of potential pitfalls.
First, the mechanical rubbing of the box against muscles and/
or soft tissue may lead to mild inﬂammation, and falsely
increase both 18F-FDG uptake and as electrical stimulation of
surrounding muscles owing to electrical leakage from the
box. Second, in the case of infection, the size of the leads
(1.5–3 mm in diameter) and of the vegetation might be
below the PET–computed tomography (CT) spatial resolu-
tion (7 mm), impairing interobserver reproducibility and diag-
nostic accuracy if 18F-FDG uptake is not very high.
The present study aimed: (i) to prospectively evaluate the
use of 18F-FDG PET-CT whole body imaging in patients sus-
pected of having sepsis after PM or ICD implantation for
positive diagnosis of infection and identiﬁcation of other sep-
tic locations; (ii) to deﬁne the best methodology for image
analysis (i.e. visual or quantitative interpretation); and (iii) to
assess interobserver reproducibility.
To quantify 18F-FDG update and determine abnormal
threshold values, a control population was prospectively
selected, consisting of asymptomatic patients referred to our
institution for oncological indications and undergoing PM or
ICD implantation at least 1 year before PET study, with sta-




All patients suspected of having device infection were con-
secutively included from 8 August 2007 to 15 September
2009. Device sepsis was clinically suspected because of: (i)
unexplained persistent or recurrent fever >38C, and/or (ii)
chronic inﬂammatory syndrome with increased C-reactive
protein, and/or (iii) positive blood culture independently of
the TTE and TEE results, and/or (iv) clinical suspicion of
pocket infection on the basis of inﬂammation and/or liquid
effusion. Consent was obtained from all patients before
examination, although 18F-FDG-PET has approval in France
for location of occult infection or in cases of fever of
unknown origin. These patients constituted group 1. Analysis
was independent of sex, age, reason for implantation, date of
implantation and device type.
Control group: group 2
In the same time period, 14 patients with asymptomatic
implanted PM, referred for PET-CT imaging in our institution
for oncological purposes, were prospectively included.
Patients were selected independently of sex, age and reason
for implantation. Clinical and biological infectious syndrome
was an exclusion criterion, but did not, in fact, occur in this
group.
Final diagnosis
The decision on device extraction was made without taking
account of PET results. However, in the case of other sep-
tic locations being discovered on PET, this information was
transmitted to the clinician. The ﬁnal diagnosis of presence
or absence of infection was based either on bacteriology
(blood culture or device analysis performed after device
extraction) or, when no device was extracted, on a pro-
longed follow-up of 6 months with modiﬁed Duke’s criteria
[10]. Patients with clinical suspicion of device infection and
presenting infectious endocarditis according to these criteria
were considered to be positive for device infection. Diag-
nosis was ruled out if clinical symptoms and/or biological
abnormalities returned to normal during this follow-up
without fulﬁlling the modiﬁed Duke’s criteria; if not, and if
no other aetiology was found, device extraction was
decided on.
18F-FDG PET acquisition
Whole body PET-CT imaging was performed on a dedi-
cated Philips Gemini PET/CT system (Philips Medical Sys-
tems, Andover, MA, USA) after intravenous administration
of 5 MBq/kg of 18F-FDG (maximum, 500 MBq) in patients
at rest, after an 8-h fasting period. PET-CT imaging was
performed 1 h after 18F-FDG injection, with scanning from
the base of the skull to above knee level. The CT acquisi-
tion parameters were as follows: 4-mm-thick transaxial
images; pitch, 1.5; 120 kV and 120–160 mAs; slice thickness,
5 mm with rebuilding in 2-mm slices every 2 mm; pitch, 1;
collimation, 16 · 1.5; standard resolution; and ﬁeld of view,
600 mm. No oral or intravenous contrast was used. PET
data were acquired in three-dimensional mode, at 2 min
per step. Non-attenuation-corrected slices, slices corrected
for attenuation by an iterative method (three-dimensional
high-resolution Row Action Maximum Likelihood Algorithm)
and a CT attenuation map were reconstructed. The native
PET slice thickness was 4 mm. Glycaemia was controlled at
the time of the study, and was <9 mM in all consecutive
patients, even though glycaemia was not a criterion for
patient exclusion.
Data management
Visual analysis. Data for both groups were ﬁrst visually analy-
sed by two independent observers, blind to the clinical and
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bacteriological data and to the other imaging modalities, on a
Brilliance 190 XP monitor (Philips Healthcare, Cleveland,
OH, USA). Image interpretation initially consisted of quality
control with maximum intensity projection analysis; visual
analysis was then performed with attenuation-corrected and
non-attenuation-corrected images and fusion with CT slices
for each dataset. Then, on the basis of the presence and
intensity of hot spots around box and/or leads in group 1
patients, each observer classiﬁed the case as positive or neg-
ative for box infection, lead infection and device infection,
independently of the septic location.
Quantitative analysis. In group 1, quantitative analysis was car-
ried out by computing 18F-FDG maximal standard uptake
value (SUVmax) inside a circular region of interest (ROI) of
5-mm radius around the most intense uptake over the cuta-
neous side of the box, over the muscle side of the box and
over each hot spot on the leads, when present, or else over
the most intense 18F-FDG uptake spot over the leads, with a
maximum of ﬁve ROIs on the leads.
Similar ROIs were drawn in group 2 over the boxes.
As none of the patients in this control group showed
visually signiﬁcant uptake over the leads, ROIs were placed
over the leads on standardized slices deﬁned as crossing
the middle of the body of the second, ﬁfth and seventh
vertebrae.
Statistical analysis
Interobserver reproducibility was evaluated with a Cohen
kappa test [11] for qualitative data (presence or absence of
infection on box, lead or both), and judged to be bad for
kappa <0.20, poor between 0.21 and 0.40, average between
0.41 and 0.6, fair between 0.61 and 0.8, and excellent above
0.81. A ﬁnal consensus reading was performed in the case of
discrepancies.
Quantitative data were compared with paired or non-




Patients suspected of device infection: group 1 (n = 21). Twenty-
one patients were prospectively included. Devices were
PMs in 18 patients and ICDs in three, all implanted in
the thorax. Device infection was suspected because of:
(i) unexplained persistent or recurrent fever >38C (n = 17),
and/or (ii) chronic inﬂammatory syndrome with increased
C-reactive protein (n = 15), and/or (iii) positive blood
culture (n = 11) independently of the TTE and TEE
results, and/or (iv) clinical suspicion of pocket infection on
the basis of inﬂammation and/or liquid effusion (n = 5)
(Table 1).
Fifteen of the 21 patients were receiving antibiotic treat-
ment at the time of PET-CT imaging, for a mean
12.05 ± 7 days.
Devices were explanted from 11 patients (one later, dur-
ing follow-up) and bacteriological proof of infection was
obtained (by culture) for eight of them.
In the ten remaining (non-explanted) patients and during
follow-up (8.3 ± 2.6 months), infection was conﬁrmed in
one patient on device culture (obtained post-mortem).
Another showed three minor criteria for septicaemia [10]:
persistent fever >38C, positive blood culture (Streptococcus
mitis) and mitral bioprosthesis for mitral regurgitation.
This patient was considered to be positive and treated
accordingly.
Thus, diagnosis of infection was conﬁrmed in ten of 21
patients and was not conﬁrmed in 11. The bacteria identiﬁed
were: Klebsiella pneumoniae (n = 1), Corynebacterium jeikeium
(n = 1), Streptococcus sanguinis (n = 1), S. mitis (n = 1), methi-
cillin-resistant coagulase-negative Staphylococcus (n = 1), Esc-
herichia coli (n = 1), Pseudomonas aeruginosa (n = 1), and
methicillin-sensitive coagulase-negative Staphylococcus (n = 3).
In the 11 patients without conﬁrmed device infection,
symptoms disappeared during follow-up within
2.3 ± 0.9 months in nine cases and persisted without further
evidence of device sepsis in two others with a follow-up of
7.3 ± 1.2 months. One of these two patients had a pattern
of aortitis on PET images; the other had (previously known)
sepsis of the tarsal bone.
Echocardiographic ﬁndings
TTE was performed in all patients and TEE in 16. TTE was
not performed in ﬁve patients, because of their clinical sta-
tus.
TTE clearly demonstrated vegetations in two patients
(conﬁrmed by TEE).
TTE was questionable, showing a suspicious image of veg-
etation in three others. Nevertheless, infection was con-
ﬁrmed neither by the follow-up nor by TEE in two of them.
TEE was not performed for the latter, because of his clinical
status, but the follow-up showed an absence of device infec-
tion. TEE revealed vegetations in three other patients that
were not seen with TTE.
Control group: group 2 (n = 14). The mean follow-up for the
14 control patients was 18 ± 6.4 months, and all patients
were free of any clinical or biological infectious event.
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Positive diagnosis of infection: visual analysis
In the 21 group 1 patients, visual analysis of PET images
revealed 42 hot spots: 21 on the boxes and 21 on the leads.
On patient-based analysis, eight were true-positive, 11
true-negative, two false-negative and none false-positive, giv-
ing sensitivity, speciﬁcity, positive predictive value, negative
predictive value and accuracy of, respectively, 80%, 100%,
100%, 84.6% and 90.4%. The explanted patient in whom
device infection was not conﬁrmed during follow-up had a
negative PET ﬁnding, whereas the patient explanted
3 months later and for whom infection was bacteriologically
proven (post-mortem) had a positive PET ﬁnding at the time
of inclusion. The patient who had three minor criteria
according to Duke’s classiﬁcation had a negative PET ﬁnding.
On site-by-site analysis, 27 devices were free of hot spots
and were true-negative, and four were false-negative. Diag-
nostic accuracy was better for boxes (100%) than for leads
(80.9%). For boxes, ﬁve hot spots were true-positive, all pro-
ven bacteriologically after device explantation (C. jeikeium
(n = 1), P. aeruginosa (n = 1), K. pneumonia (n = 1), S. sangui-
nis (n = 1) and Staphylococcus (n = 1)), 16 boxes were true-
negative, and none were false-negative or false-positive. Only
three of the ﬁve patients with bacteriologically conﬁrmed
pocket infection were clinically suspected. In two patients
referred for PET because of clinical suspicion of pocket infec-
tion, infection was not conﬁrmed during a follow-up of more
than 6 months, and symptoms disappeared 1 and 3 months
after examination. For leads, six hot spots were true-positive,
TABLE 1. Group 1 population
Group 1
Department
of origin Clinical symptoms
Biological







1 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP L + Escherichia coli Negative Negative E. coli +
2 Cardiology Unexplained persistent or
recurrent fever >38C
) + Staphylococcus Negative Negative 8 )
3 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP ) ) Negative Negative 7 )
4 Cardiology Peak of fever >38C for 48 h Increased CRP ) ) Questionable Negative 11 )
5 Internal Medicine Unexplained persistent or
recurrent fever >38C
) + Staphylococcus Negative Negative )
6 Internal Medicine Unexplained persistent or
recurrent fever >38C
Increased CRP B ) Negative Negative Pseudomonas +
7 Cardiology Clinical suspicion of
pocket infection
Increased CRP ) + Staphylococcus Negative 7 )
8 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP ) ) Negative Positive Staphylococcus +
9 Cardiology Unexplained persistent
or recurrent fever >38C,
clinical suspicion of
pocket infection
Increased CRP P ) Positive Positive Streptococcus +
10 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP L + Staphylococcus Negative Negative Staphylococcus
post-mortem
6 +
11 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP ) ) Negative Negative 8 )
12 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP L + Staphylococcus Positive Positive Staphylococcus +
13 Cardiology Unexplained persistent





Negative Positive K. pneumonia +
14 Cardiology Persistent biological
syndrom >2 months
Increased CRP ) + Staphylococcus Negative Negative 9 )
15 Cardiology Unexplained persistent or
recurrent fever >38C
) + Staphylococcus Questionable Negative )
16 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP ) + Streptococcus
mitis
Negative 6 +




P ) Negative Staphylococcus +
18 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP ) ) Negative Negative 14 )
19 Cardiology Clinical suspicion of
pocket infection
) ) Questionable Negative Negative 8 )
20 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP B + Corynebacterium Negative Positive Corynebacterium +
21 Cardiology Unexplained persistent or
recurrent fever >38C
Increased CRP ) ) Negative Negative 7 )
B, both (pocket+lead infection); BC, blood culture; CRP, C-reactive protein; FU, follow-up (months); L, lead infection; P, pocket infection; ; TEE, transoeosophagal; PET,
positron emission tomography; TTE, transthoracic.
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11 patients did not show hot spots on leads and were
true-negative, four were false-negative and none were false-
positive (Table 2). Thus, sensitivity, speciﬁcity, positive pre-
dictive value and negative predictive value were all 100% for
boxes and, respectively, 60%, 100%, 100% and 73% for leads.
Regarding lead infection, the four false-negative cases
received antibiotic treatment for signiﬁcantly longer than the
six true-positive cases (20 ± 7.2 vs. 3.2 ± 2.3 days; p <0.01).
Extension of infectious disease
In four group 1 patients with bacteriologically proven infec-
tion, 18F-FDG PET revealed other unknown abnormalities:
associated lung infection (n = 2, conﬁrmed by CT and by fol-
low-up), infection of right ventricle/pulmonary artery pros-
thetic tube (n = 1, conﬁrmed by culture after surgery) and
aortitis (n = 1, conﬁrmed by TEE and follow-up). Further-
more, PET conﬁrmed a sepsis of the tarsal bone in one
other patient, which was clinically suspected, previously doc-
umented by bone scintigraphy and conﬁrmed by biopsy.
Interobserver reproducibility of visual analysis
Kappa values for patient classiﬁcation (presence or absence
of device infection), pocket infection (presence or absence)
and lead infection (presence or absence) were, respectively,
0.80, 0.89 and 0.79.
Quantitative analysis
Boxes. In controls (group 2), the mild, diffuse 18F-FDG
uptake in soft tissue on the side of the box facing the mus-
cles was signiﬁcantly higher than that on the opposite side
(skin): SUVmax = 1.70 ± 0.52 vs. 1.13 ± 0.48; p <0.01.
In group 1 patients with no box infection, the SUVmax val-
ues for 18F-FDG uptake on the muscle and skin sides were,
respectively, 1.95 ± 0.61 and 1.22 ± 0.57 (p <0.01); these
values were not signiﬁcantly different from those of controls
(group 2).
In patients with conﬁrmed box infection, the involved
sides showed greater and heterogeneous uptake, comprising
diffuse uptake with more intense hot spots. Average uptake
values were signiﬁcantly higher than in controls (respectively,
SUVmax = 4.72 ± 1.68 and 1.70 ± 0.52; p <0.01).
An SUVmax cut-off value equal to or >2.2 (mean control
value + 1 standard deviation) discriminated all infected
patients from controls (Fig. 1).
Leads. Average 18F-FDG uptake was not signiﬁcantly differ-
ent between the two groups: SUVmax = 1.87 ± 0.41
(group 2) vs. 1.68 ± 0.38 (group 1) (not signiﬁcant (NS)). A
slightly elevated focal uptake over the lead was more valu-
able for the diagnosis of sepsis than the overall uptake value
itself.
Discussion
Fifty thousand PMs per year and 43 ICDs per year and per
million inhabitants are implanted in France. Infection of these
devices may involve either the site of the box (pocket) (0.5–
5% of cases) or the leads themselves (0.8–4.9% of cases)
[1,2]. Thus, the incidence of device infection appears to be
similar to that of other infections on prosthetic material.
There is no established reference standard for assessing
device infection. When, however, it is present, patients with
device infection are managed as for endocarditis. We there-
fore used Modiﬁed Duke’s criteria, the reference standard in
FIG. 1. Plot of standard uptake value of [18F]ﬂuorodeoxyglucose
uptake around boxes between controls (group 2, left) and patients
(group 1, right). A maximal standard uptake value (SUVmax) thresh-
old value equal to or >2.2 completely separates controls (left) and
non-infected patients on the one hand (right column below the mar-
ker) and infected patients on the other hand.
TABLE 2. Diagnostic accuracy according to site of infection:
box only, leads only, box and leads (both sites) and box or






True-positive 5 6 11 8
True-negative 16 11 27 11
False-positive 0 0 0 0
False-negative 0 4 4 2
Sensitivity (%) 100 60 73.3 80
Speciﬁcity (%) 100 100 100 100
PPV (%) 100 100 100 100
NPV (%) 100 73.3 87 84.6
PPV, positive predictive value; NPV, negative predictive value.
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endocarditis, comprising two major criteria: (i) typical organ-
ism in two separate blood cultures or persistently positive
blood cultures; and (ii) presence of vegetation or abscess on
echocardiogram or recent valvular regurgitation; and ﬁve
minor criteria—(a) cardiac predisposition, such as previous
valvular disease; (b) fever over 38C; (c) cutaneous vascular
and/or immunological phenomena of endocarditis; (d)
positive blood culture with pathogens not found with the
major criteria (atypical organism); and (e) echocardiographic
abnormalities other than those found with the major criteria.
Positive diagnosis of endocarditis is based upon the presence
of two major criteria, or one major criterion plus three
minor criteria, or ﬁve minor criteria [10].
It might be useful to assess the extension of infectious dis-
ease (staging) in these patients by non-invasive whole body
imaging, and 18F-FDG PET is a potential candidate for this
purpose. To date, only three case reports have shown hot
spots on leads related to conﬁrmed infection [12–14]; no
prospective series have been reported.
The aim of the present preliminary study was to evaluate
the potential use of this imaging method by deﬁning the best
criteria for positive diagnosis. The results suggest that
18F-FDG PET shows high diagnostic accuracy when infection
affects the box (Fig. 2) and is slightly less reliable when the
leads are involved.
Physiologically (Fig. 3), slight 18F-FDG uptake may be
observed around the box, particularly in front of the muscle
interface in controls. False enhancement on attenuation-cor-
rected images may be related to a metallic artefact resulting
from the box itself, which can easily be prevented by com-
parison with non-attenuation-corrected images. Although
uptake around the box is much higher in cases of infection
than in controls, the physiological uptake seen in controls
might be confusing for inexperienced observers and could be
explained by mild, non-speciﬁc inﬂammation caused by rub-
bing of skin and soft tissue against the box. Another possibil-
ity is diffusion of low-intensity impulses within adjacent
muscular structures, leading to muscular activity of a low
level but sufﬁcient to generate a signiﬁcant difference in mus-
cular metabolism. Therefore, 18F-FDG uptake quantiﬁcation
might be useful during the learning-curve phase, as visual
analysis requires a higher level of uptake than on other sites
to allow a conclusion in favour of infection. In any case,
because of the high uptake intensity in patients with infection
and the size of the device itself, which is much larger than
the resolution of the PET system, negative predictive value
and reproducibility appear to be very high.
Diagnosis of lead infection represents a different challenge.
First, the leads and the the vegetation are both very small,
and may easily be below the theoretical resolution of the
PET system. However, with PET imaging, current practice
demonstrates that even an object that is small in comparison
with the system’s resolution may be seen if tracer uptake is
very high. According to this hypothesis, the so-called partial
volume effects, resulting from the mild spatial resolution of
the PET system, may decrease the apparent uptake, explain-
ing why the tracer uptake intensity on images in the present
series was very mild, impairing interobserver reproducibility
during the learning phase. Because of the individual variability
in tracer uptake and in circulating tracer, as shown by the
similar standard deviations of SUVmax in infected patients and
in controls, quantiﬁcation is not useful for positive diagnosis
of lead infection, which is, rather, based visually, case by
case, on the presence of low to moderate hot spots on the
FIG. 2. Box infection. Top: transverse
(left), sagittal (medium) and coronal
(right) positron emission tomography
slices through the box. High [18F]ﬂuoro-
deoxyglucose uptake indicates pocket
infection. Bottom: corresponding com-
puted tomography slices.
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lead itself (Figs 4 and 5). Because reproducibility for leads
was weaker than for boxes, a learning curve is required, and
dual interpretation should be performed.
Any intricate factor that can decrease tracer uptake
entails a risk of false-negative cases. It should be emphasized
that, in the present series, the false negatives were patients
who received antibiotic therapy for the longest time.
Although this needs to be conﬁrmed in larger series,
interpretation of negative predictive values should be per-
formed with care in cases of treatment duration of more
than 7 days. One of the false-negative cases fulﬁlled only
three of ﬁve Duke’s criteria, but was ﬁnally considered to be
positive by clinicians and treated accordingly. This classiﬁca-
tion as positive may be questionable, and had the effect of
increasing the number of false negatives and thus decreasing
the assessed accuracy of PET.
FIG. 3. Physiological uptake around the
box (control patient). Top: transverse
(left), sagittal (medium) and coronal
(right) positron emission tomography
slices through the box. The mild
[18F]ﬂuorodeoxyglucose uptake is usual
and does not indicate any infectious
process. Bottom: corresponding com-
puted tomography slices. SUV, standard
uptake value.
FIG. 4. Lead infection. Top: transverse
(left), sagittal (medium) and coronal
(right) slices displaying a focal hot spot
on a lead (circle), indicating lead infec-
tion. Bottom: corresponding computed
tomography slices.
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Conversely, no false-positive cases were reported.
Recent blood thrombi have been reported to show 18F-
FDG uptake [15,16], but the inﬂammatory process that can
be subsequently induced is probably less than that induced
by septic foci. This point needs to be conﬁrmed in further
studies, as no such case actually occurred in the present
series.
The study was not designed to address the impact of PET
results on patient management: decisions were taken by clini-
cians independently of these results. A prospective study will
be required to answer this question. Nevertheless, it was
noteworthy that the only patient who was explanted and did
not show device infection had negative PET ﬁndings, whereas
the only one who was not initially explanted and did show
device infection during follow-up had positive PET ﬁndings.
As PET also revealed other infectious foci in three patients
and an associated inﬂammatory disease in one, the change in
patient management induced by PET could have concerned
six of 21 patients (28%).
Conclusion
18F-FDG PET imaging may be useful for the diagnosis of
device infection after PM or ICD implantation. For boxes,
sensitivity and speciﬁcity are optimal even though mild physi-
ological uptake may be seen in normal cases. For leads, sen-
sitivity and reproducibility are more problematic, and
diagnosis is based upon visualization of mild focal uptake
along the leads. Interpretation of negative cases should be
cautious if patients have received prolonged antibiotherapy.
Although the study was not designed for this purpose, man-
agement could have been modiﬁed by PET results in six of
21 patients.
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